Evidence map›Paper›PMID 41142909›Full record

ArticlePatterns (New York, N.Y.)2025

Hierarchical affinity landscape navigation through learning a shared pocket-ligand space.

Bin Feng, Zijing Liu, Hao Li, Mingjun Yang, Junjie Zou, He Cao, Yu Li, Lei Zhang, Sheng Wang

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bin FengInternational Digital Economy Academy (IDEA), Shenzhen, China.
Zijing LiuInternational Digital Economy Academy (IDEA), Shenzhen, China.
Hao LiInternational Digital Economy Academy (IDEA), Shenzhen, China.
Mingjun YangXtalPi Co., Ltd., Shenzhen, China.
Junjie ZouXtalPi Co., Ltd., Shenzhen, China.
He CaoInternational Digital Economy Academy (IDEA), Shenzhen, China.
Yu LiInternational Digital Economy Academy (IDEA), Shenzhen, China.
Lei ZhangInternational Digital Economy Academy (IDEA), Shenzhen, China.
Sheng WangPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structure of the protein binding pocket governs the ligand binding affinity by providing crucial intermolecular interactions and spatial compatibility. While existing methods have leveraged these structural insights to advance affinity prediction, they often treat virtual screening and hit-to-lead optimization separately, mainly due to incompatible speed-accuracy requirements. However, these two tasks complement each other, and their integration enables broader chemical exploration while preserving focus on affinity-determining substructures. Here, we present ligand unified affinity (LigUnity), a foundation model for affinity prediction that jointly embeds ligands and pockets into a shared space. In particular, LigUnity learns coarse-grained active/inactive distinction through scaffold discrimination and fine-grained pocket-specific ligand preference through pharmacophore ranking. We demonstrate the effectiveness and versatility of LigUnity on eight benchmarks across six settings. In virtual screening, LigUnity outperforms 24 methods with >50% improvement and demonstrates robust generalization to novel targets. In hit-to-lead optimization, it achieves state-of-the-art performance across split-by-time, split-by-scaffold, and split-by-unit settings, emerging as a cost-efficient alternative to free energy perturbation. We further showcase how LigUnity can be employed in an active learning framework for tyrosine kinase 2 (TYK2) to efficiently find optimal ligands. Collectively, these results establish LigUnity as a versatile foundation model for affinity prediction, offering broad applicability across the drug discovery pipeline.

Indexed as

affinity predictionhit-to-lead optimizationpharmacophore rankingscaffold discriminationshared spacevirtual screening

Identifiers

PMID41142909
PMCPMC12546767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.